# Vemulkonda Koneti Rao, M.D., Bethesda, MD – FDA Inspections

Source: https://www.keypedia.com/companies/vemulkonda-koneti-rao-md/1077f51d-4271-4061-bde8-34e77e0e820a

> Inspection records and compliance data for Vemulkonda Koneti Rao, M.D. in Bethesda, Maryland. 2 FDA inspections on record, 1 Form 483, last inspected October 29, 2025.

---

## Details

- Name: Vemulkonda Koneti Rao, M.D.
- FEI Number: 3023709962
- Address Line 1: National Institutes Of Health Clinical Center, 10 Center Dr
- City: Bethesda
- State: Maryland
- Zip Code: 20892
- Country Name: United States
- Address: National Institutes Of Health Clinical Center, 10 Center Dr, Bethesda, Maryland 20892, United States
- Country: United States

## Related Documents

- [483 - Vemulkonda Koneti Rao, M.D. - 2025-10-29](https://www.keypedia.com/records/483/vemulkonda-koneti-rao-md/db0356a3-4cbe-4992-9aa8-78e33abbbfbb) — source: FDA, date: October 29, 2025
- [FDA Inspection 1289862 - Vemulkonda Koneti Rao, M.D. - 2025-10-29](https://www.keypedia.com/records/fda_inspections/vemulkonda-koneti-rao-md/e6668461-db55-471c-8e90-81362dc32e17) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 29, 2025
- FDA Inspection 1289862 - Vemulkonda Koneti Rao, M.D. - 2025-10-29 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 29, 2025
- [483 - Vemulkonda Koneti Rao, M.D. - 2022-10-07](https://www.keypedia.com/records/483/vemulkonda-koneti-rao-md/58c62d33-f9c8-4096-8a74-ebb0cc54c3ec) — source: FDA, date: October 7, 2022
- [FDA Inspection 1181170 - Vemulkonda Koneti Rao, M.D. - 2022-10-07](https://www.keypedia.com/records/fda_inspections/vemulkonda-koneti-rao-md/1fe5a894-68e2-49b4-9482-264bef0408b5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 7, 2022

## Related Companies

- [OurPharma LLC](https://www.keypedia.com/companies/ourpharma-llc/2172e4a8-770c-45d9-9eb6-0321c8ba396f)
- [First Time US Generics LLC](https://www.keypedia.com/companies/first-time-us-generics-llc/f6359b6c-cd28-4749-a4da-8187845004bf)
- [Daniel Norman, M.D.](https://www.keypedia.com/companies/daniel-norman-md/bd34bdd0-4f58-4a86-9a6d-0cfc983e300c)
- [Keith A. Aqua, M.D.](https://www.keypedia.com/companies/keith-a-aqua-md/1b09891f-72da-4ee0-b524-946275c5044f)
- [Paramesh Banerji Life Sciences, LLC](https://www.keypedia.com/companies/paramesh-banerji-life-sciences-llc/8a5dcf24-e253-4116-a968-f9b1a890d15b)
- [BRI Institutional Review Board, Inc.](https://www.keypedia.com/companies/bri-institutional-review-board-inc/27f73a19-9417-4b75-90db-3cd132eddbb1)
- [Axsome Therapeutics, Inc.](https://www.keypedia.com/companies/axsome-therapeutics-inc/0bc3d1e2-dfe0-47ba-b144-4248f1fdfdf0)
- [University Rx Specialist, dba University Compounding Pharmacy](https://www.keypedia.com/companies/university-rx-specialist-dba-university-compounding-pharmacy/12a3316a-d0c4-4f6a-9825-89f40e86bdb9)
- [Ehsan Sadri MD](https://www.keypedia.com/companies/ehsan-sadri-md/0886b863-2ee6-464f-801d-f13278a9b974)
- [Puremedy Inc.](https://www.keypedia.com/companies/puremedy-inc/89f36894-f42e-4af8-981c-d06ccb5c6514)

## Related Officers

- [investigator](https://www.keypedia.com/people/stephanie-c-mangigian/0cf25e6b-1e5d-4088-a13c-11483e2380ba)
- [Consumer Safety Officer/BIMO Investigator](https://www.keypedia.com/people/david-l-chon/227b9c21-14c4-442b-bdc3-ad167567fd92)
- [Lucilla Facchin](https://www.keypedia.com/people/lucilla-facchin/e5c5c863-b2f4-44a8-8093-d1cb4f71949b)
